SEC EDGAR filings, ownership reports, and insider transactions for A2A Pharmaceuticals, Inc..
Recent SEC filings for A2A Pharmaceuticals, Inc. including 4, 144, 4/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jun 2023 | 31 May 2023 | 001-40335 |
| 144 | Open 144 document | View SEC filing for 144 | 19 May 2023 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 May 2023 | 12 May 2023 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 May 2023 | 08 May 2023 | 001-40335 |
| 144 | Open 144 document | View SEC filing for 144 | 27 Apr 2023 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Apr 2023 | 20 Apr 2023 | 001-40335 |
| 144 | Open 144 document | View SEC filing for 144 | 20 Apr 2023 | |||
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 06 Apr 2023 | 31 Mar 2023 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Apr 2023 | 31 Mar 2023 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2022 | 16 Aug 2022 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Jul 2022 | 21 Jul 2022 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Jun 2022 | 24 Jun 2022 | 001-40335 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Sep 2021 | 17 Sep 2021 | 001-40335 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 26 Apr 2021 | 15 Apr 2021 | 001-40335 |
A2A Pharmaceuticals, Inc. files with the SEC under CIK 0001859061. This page aggregates EDGAR filings and related ownership activity.